Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient Needs

Although patient preferences have been studied broadly for marketed products or around the time of submission to authorities and launch, patient preference studies have rarely been used during the early drug development phases. In this paper, we formulate three hypotheses supporting the use of patie...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nigel S. Cook, Julie Cave, Anke-Peggy Holtorf
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2019-04-01
coleção:	Frontiers in Medicine
Assuntos:	patient preferences patient-based evidence multi-stakeholder dialog drug development health technology assessment (HTA) dry eye disease
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fmed.2019.00082/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!